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DNA methylation patterns are important for establishing cell, tissue, and organism phenotypes, but little is known about
their contribution to natural human variation. To determine their contribution to variability, we have generated genome-
scale DNA methylation profiles of three human populations (Caucasian-American, African-American, and Han Chinese-
American) and examined the differentially methylated CpG sites. The distinctly methylated genes identified suggest an
influence of DNA methylation on phenotype differences, such as susceptibility to certain diseases and pathogens, and
response to drugs and environmental agents. DNA methylation differences can be partially traced back to genetic var-
iation, suggesting that differentially methylated CpG sites serve as evolutionarily established mediators between the
genetic code and phenotypic variability. Notably, one-third of the DNAmethylation differences were not associated with
any genetic variation, suggesting that variation in population-specific sites takes place at the genetic and epigenetic levels,
highlighting the contribution of epigenetic modification to natural human variation.
[Supplemental material is available for this article.]
Phenotypic differences between individuals cannot entirely be
explained by genetic differences. Considering the transcriptome as
a mirror of the sum of regulatory events suggests that nongenetic
mechanisms have a profound influence on the phenotype. Epi-
genetics is responsible for part of this additional layer of control
(Feinberg 2007; Portela and Esteller 2010). For example, genetically
identical individuals, such asmonozygotic twins (Fraga et al. 2005;
Kaminsky et al. 2009), cloned animals (Rideout et al. 2001), and
Agoutimice (Michaud et al. 1994;Waterland and Jirtle 2003), show
DNAmethylation and phenotypical differences. Hence, epigenetic
variations, and in particular DNA methylation, might participate
not only in differences between individuals, but also between
human populations, and could contribute to the observed differ-
ences in distinct physical appearance, behavior, and response to
environmental agents and drugs. In this regard, the presence of
DNAmethylation differences between anAfrican and an European
population using a 27,000-CpG-site microarray platform has been
previously reported (Fraser et al. 2012).
DNA methylation at gene promoters is important for tran-
scriptional regulation, with dense promoter hypermethylation
around the transcription start site being associated with gene re-
pression (Feinberg 2007; Portela and Esteller 2010). The picture is,
in fact, more complex, and, recently, intragenic methylation has
been linked to transcriptional and splicing activities ( Jones 2012),
suggesting a sophisticated regulatory potential for this epigenetic
modification. DNA methylation levels are closely related to the ge-
nomic context, with CpG-rich regions (CpG islands) located in the
59 endof genes beingpredominantly unmethylated. Interindividual
variation in DNAmethylation at distinct CpG sites has consistently
been linked to genetic variation in terms of single nucleotide
polymorphisms (SNPs) and defined as methylation quantitative
trait loci (meQTL) (Bell et al. 2011, 2012). However, the causal chain
of events establishing DNA methylation variability, which is cur-
rently under debate, is likely to bemediated in anetwork of genomic
contexts, transcriptional activity, and additional epigenetic layers of
regulation, such as histone modifications, DNA binding and mod-
ifying factors, nucleosome positioning, and noncoding RNAs.
Many genome-wide association studies (GWAS)have attempted
to establish genetic associations with differences between distinct
populations (Li et al. 2008a; Lachance et al. 2012), diseases (Kamatani
et al. 2009), and the response to external stimuli (Li et al. 2008b; Niu
et al. 2010). However, fewer associationswere observed than expected,
and direct genotype–phenotype relations were not easily explica-
ble since themajority of variant sites are located in noncoding loci
(Kilpinen and Dermitzakis 2012). In this context, the epigenetic
network is expected to add layers of regulation, suggesting an in-
terplay between the genotype and epitype in gene regulation and
phenotypic variation (The ENCODE Project Consortium 2012).
In this study,weperformeddifferentialDNAmethylation analysis
of around300 individuals fromthreehumanpopulations. Inparticular,
we analyzed B-lymphocytes obtained from Caucasian-American,
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African-American, and Han Chinese-American individuals at a ge-
nome-scale resolution of around 450,000 CpG sites (Dedeurwaerder
et al. 2011; Sandoval et al. 2011). DNA methylation levels at dis-
tinct loci enabled their separation with respect to geographic ori-
gin and could help explain natural human variation. A subsequent
integration of genotype data enabled the precise separation into
genetically dependent and independent variation.
Results
DNA methylation differences are present in distinct human
populations
We determined differences in DNA methylation between three
populations extensively characterized in the Human Variation
Panel in terms of single nucleotide polymorphisms (SNPs) and
gene expression (Li et al. 2008b; Niu et al. 2010). The DNA meth-
ylation profile was assessed for 288 B-cell lymphoblastoid cell lines
(LCL) representing 96 Caucasian-American (CA), 96 African-
American (AF), and 96 Han Chinese-American (AS) individuals.
After sample randomization, DNA samples were hybridized on the
Infinium DNA methylation BeadChip platform (Illumina), which
analyzesmore than450,000CpGsites in the genome (Dedeurwaerder
et al. 2011; Sandoval et al. 2011). After normalization, we filtered
out poor-quality probes and those containing single nucleotide
polymorphisms (SNPs; >1%) (The 1000 Genomes Project Consor-
tium 2010) and copy number variations (CNV; >5%) (Redon et al.
2006) in the detection sequence: Following these filters, from the
originally printed 485,577 CpG sites in the microarray, we main-
tained 406,021 probes for subsequent analysis. Any DNA meth-
ylation variation introduced by Epstein-Barr virus (EBV) immor-
talization of the LCLs was also excluded by positive filtering for
variant CpG sites between 10 Caucasian, 10 Asian, and 10 African
naive peripheral blood cell samples. Nonetheless, 1373 differen-
tially methylated CpG sites (delta mean b-values $0.12; ANOVA,
FDR < 0.01) separately generated only from LCL samples were able
to cluster naive blood samples perfectly according to their geo-
graphical origin, underscoring the capability of LCL samples to
determine epigenetic differences between ethnicities (Supple-
mental Fig. S1). Herein, we determined 439 CpG sites to be dif-
ferentially methylated between the populations both in LCL
and naive blood samples (delta mean b-values $ 0.12; ANOVA
with Tukey HSD post hoc test, FDR < 0.01) (Fig. 1A; Supplemental
Table S1) and were able to cluster them separately (multiscale
bootstrap resampling, n = 10,000, approximately unbiased P-value >
0.99) (Fig. 1B). The DNA methylation classification originated a
separate branch for AF, and in the other arm of the cluster, two
subbranches were obtained corresponding to CA and AS, consistent
with the accepted prior genetically defined proximities (Fig. 1A; Li
et al. 2008a). These CpG sites with population-specific differential
methylationwere termed pop-CpGs. Particularly, 172, 129, and 138
CpG sites revealed DNA methylation that differed significantly
in AF, CA, and AS samples, respectively. Four hundred thirty-nine
randomly selected probes were not able to separate the individuals
with respect to their population identity (multiscale bootstrap
resampling, n = 10,000).
PCA with the pop-CpGs to apportion the majority of the
variation clearly separated the samples with respect to their pop-
ulation identity and identified the ethnic relationship as the
strongest component (Fig. 1C). We also performed surrogate vari-
able analysis (SVA) to exclude covariates, other than population
association, that drove the separation of the samples. SVA did not
detect any surrogate variables, such as batch effects, excluding
unknown, unmodeled, or latent source of noise influencing our
results. To confirm the common ancestral DNAmethylation status
within the populations, we performed ADMIXTURE, applying
three DNA methylation scenarios (unmethylated: <0.33; hemi-
methylated: $0.33, #0.66; methylated >0.66). Here, the analyzed
individuals segregated into their assigned populations, displaying
common ancestral DNA methylation levels within populations
and distinct levels between populations (Fig. 1D).
Out of 439 pop-CpGs, 178 were located in gene promoter
regions (including 51 noncoding RNA promoters, GENCODE v13)
(Supplemental Table S2), 147 in gene bodies, and 114 in intergenic
regions (Supplemental Fig. S2A; Supplemental Table S1). Consid-
ering the regional CpG composition and density, 104 pop-CpGs
mapped to CpG islands, 124 to CpG island shores, 36 to CpG is-
land shelves, and 175 CpGs outside of the island context (‘‘open
sea’’) (Supplemental Fig. S2B). Furthermore, we analyzed histone
occupancy frequencies extracted from the genome-wide epige-
netic mapping determined for an LCL (GM12878) within the
ENCODE project at the 439 pop-CpGs (Ernst et al. 2011). Sepa-
rately analyzing promoter, gene body, and intergenic frequencies
revealed an enrichment of pop-CpGs in respect to their repre-
sentation on the array platform within the enhancer marks
H3K27ac and H3K4me1 in intragenic regions and within the
heterochromatin mark H3K9me3 at intergenic loci (Fisher’s
exact test; P < 0.05) (Supplemental Table S3). In addition to
Figure 1. DNA methylation separates African-American (AF, brown),
Caucasian-American (CA, pink), and Han Chinese-American (AS, yellow)
individuals. (A) Hierarchical clustering of 439 pop-CpG sites separating the
three populations using absolute DNA methylation levels (low: green;
high: red). (B) Multiscale bootstrap resampling (n = 10,000) of the 439
pop-CpG sites significantly differentially methylated between African,
Asian, and Caucasian individuals. The three populations cluster sepa-
rately and consistently with prior genetically defined proximities (ap-
proximately unbiased P-value > 0.99). (C ) Principal component analysis
(PCA) of pop-CpGs displaying the first two principal components.
(D) ADMIXTURE analysis of pop-CpGs-defined ancestral DNA methyla-
tion status. Each individual is represented by a vertical line, with the
lengths corresponding to the ancestry coefficients in up to three inferred
ancestral groups.
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intragenic enhancer regions, pop-CpGs revealed enrichment in
insulator sites marked by CTCF and underlining the importance of
regulatory elements outside the promoter context for natural hu-
man variation. Multiple hypotheses testing highlighted the sig-
nificant enrichment of pop-CpGs for H3K4me1 (FDR = 0.0324)
and CTCF (FDR = 0.0378) in intragenic regions (Supplemental
Table S3).
To further dissect functional consequences related to differ-
entially methylated pop-CpG sites, we performed enrichment
analysis for DNA sequence motifs (Supplemental Fig. S3). Outside
the promoter context, we identified an enrichment of DNAmotifs
related to the transcription factor RREB1 (ras responsive element
binding protein 1) in respect to the representation on the DNA
methylation array (Hypergeometric test; P < 0.01). Interestingly,
intragenic pop-CpGs also revealed an enrichment of binding sites
for the enhancer-associated factor TFAP2A (transcription factor
activating enhancer binding protein 2a) among others, under-
scoring the previous identified enrichment for the enhancer-as-
sociated histone marks H3K27ac and H3K4me1 in gene bodies.
Within gene promoter regions, we identified significant enrich-
ment of the hematopoietic transcription factors IRF1 and SPIB
(Hypergeometric test; P < 0.01) among others. Thus, pop-CpGs are
associated with histone modifications and transcription factor
binding that actively regulate gene expression, suggesting a regu-
latory network that contributes to the variance observed between
populations.
Furthermore, we aimed to determine the relationship be-
tweenDNAmethylation and transcriptional regulation. Therefore,
we integrated DNA methylation and gene expression levels and
observed significantly decreased gene expression associated to
promoter hypermethylation in 12.9% (13 out of 101) of pop-CpG-
related genes in the analyzed context (Pearson’s correlation test;
FDR < 0.01) (Supplemental Fig. S4A). This is in line with previous
studies reporting rather low overall associations between promoter
DNA methylation and gene expression (Kulis et al. 2012). It is of
note that gene body methylation was significantly associated to
gene expression in 23.9% of intragenic pop-CpGs (27 out of 113;
Pearson’s correlation test; FDR < 0.01) (Supplemental Fig. S4B).
Here, a gain of DNAmethylation was associated to gene repression
and activation in 63.0% (17 out of 27) and 37.0% (10 out of 27) of
cases, respectively.
Population-specific differential methylation contributes
to natural human variation
We expected DNA methylation in gene promoters to be directly
associated with gene expression and hence phenotype formation,
so we extracted promoter-associated pop-CpGs. We wondered
whether genes harboring pop-CpGs in their promoter could help
explain thewell-knownphenotypic variation betweenCA, AS, and
AF human populations. In this regard, pop-CpGs were located in
genes associated with natural human variation, such as xenobiotic
metabolism and transport (GSTT1, GSTM5, ABCB11, SPATC1L),
taste transducers (TAS1R3), environmental informationprocessing
and adaptation (ARNTL, PRSS3, CNR2), immune response factors
(CERK, LCK, CD226, SEPT8), growth factors (FGFR2), keratinocyte-
associated genes (KRTCAP3), and melanogenesis (CREB3L3). We
also observed the presence of pop-CpGs in genes related to the
different penetrance of diseases among distinct human pop-
ulations, such as diabetes (HLA-B/C, PRKCZ), Parkinson’s disease
onset (PM20D1), HIV infection (HIVEP3, HTATIP2, CDK11B), en-
teropathogenic Escherichia coli and measles virus infection (FYN),
and hepatitis B virus infection (HLA-DPA1). Illustrative examples
of these genes with their DNA methylation differences among
human populations are shown in Figure 2.
To distinguish between random drift at neutral loci and CpG
sites thatmayhave experienced accelerated divergence due to local
selection, we included data from 14 chimpanzee individuals from
three subspecies (Pan troglodytes troglodytes, Pan troglodytes verus,
Pan troglodytes schweinfurthii) as the outgroup in the analysis, since
this is our closest living relative. Positively selected CpG sites were
assessed by determining common ancestral sites between humans
and chimpanzees that had a single human outlier population
(ANOVA with Tukey HSD post hoc test, P < 0.05) (Supplemental
Table S4). We identified 39 CpG sites that could have evolved
under local selection pressure. These CpG sites of local adaptation
include immune (CERK, CDK11B, HTATIP2) and xenobiotic
(GSTT1, SPATC1L) response factors, suggesting that they might be
driven by differences in local pathogen and environmental pres-
sure. In particular, SPATC1L (spermatogenesis and centriole asso-
ciated 1-like) is an interesting case, because it was previously
related to the response to alkylating agents, suggesting that epi-
variation contributes to the variable response to chemothera-
peutic treatment (Fry et al. 2008). It is also tempting to speculate
that the selective pressure that gives rise to the polymorphisms
originates from carcinogens such as nitrosamides, which in-
troduce alkyl groups on guanine bases, the mechanism used by
alkylating drugs.
Cross talk between population-specific epigenetic and genetic
variants
We wondered about the effect of underlying genetic variants on
the characterized pop-CpGs. An example of the connection be-
tween ethnicity-associated epigenetic and genetic marks is the
gene SPATC1L: It was previously identified as a CpG methylation
quantitative trait loci (meQTL) and expression quantitative trait
loci (eQTL) in a lower-resolution (27,000 CpG sites) screening us-
ing Yoruba individuals (Bell et al. 2011). QTLs describe the direct
association between single nucleotide polymorphisms (SNPs) and
methylation or expression events. Accordingly, the gene expres-
sion or CpG site methylation (epitype) are directly correlating to
the underlying genetic sequence (genotype). In the present study,
we did not only validate the association between methylation and
gene expression of SPATC1L, but also established that the entire
promoter region is differentially methylated in African-Americans
with a high correlation between gene expression and the un-
derlying genotype (Fig. 3). To do this, we identified four pop-CpGs
located in the 59 end thatwere differentiallymethylated inAfrican-
Americans and directly correlated with gene expression (Fig. 3;
Supplemental Fig. S5A). All four promoter-associated pop-CpGs of
SPATC1L were assigned as meQTLs associated with a single SNP
position (rs8133082) (Fig. 3; Supplemental Fig. S6A). Interest-
ingly, we identified three pop-CpGs in the CpG island that
overlapped the transcription end site (TES) of SPATC1L with
complete inverse correlation of DNA methylation, gene expres-
sion, and genotype association with the promoter region (Fig. 3;
Supplemental Figs. S5B, S6B). Individuals with hypomethylated
and active promoters revealed hypermethylation at the TES
(Pearson’s product-moment correlation, rho = 0.89) (Supple-
mental Fig. S7). Hypermethylation at the TES of actively tran-
scribed SPATC1L might impair the high frequencies of the pre-
viously identified antisense transcription that takes place at
terminator sites (He et al. 2008).
DNA methylation contributes to human variation
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From the original observation in SPATC1L, we extended
the search of meQTLs to the entire set of 439 pop-CpGs. We
found 68% (298 of 439) of differentiallymethylated CpG siteswere
significantly related to underlying ge-
netic variation (596 SNPs, random forest
selection frequencies, FDR < 0.05) (Sup-
plemental Table S5). Because only 13% of
the randomly selected 439 CpG sites
revealed genetic association, we excluded
the common event of epitype–genotype
association of CpG sites interrogated in
this study (Fisher’s exact test, P < 0.01). To
exclude the idea that confounding effects
based on genetic differences between
the populations were driving the associ-
ation of pop-CpG methylation levels
with the underlying genotype, we per-
formedmeQTL analysis separately for the
three populations. Importantly, we con-
firmed an association to the genetic
background in at least one of the three
populations, for 91.6% (273 out of 298) of
the meQTLs, suggesting that the detected
associations are mainly independent
from ethnic variation. Furthermore, we
aimed to interrogate the tissue specificity
of epitype–genotype associations by an-
alyzing 159 normal primary specimens
representing three different solid-tissue
types. Taking advantage of genotype and
DNA methylation data available from
TheCancerGenomeAtlas (TCGA), we determined the associations
of pop-CpG sites to the underlying genetic background to be
maintained across tissue types in 60.7% (181 out of 298) of the
Figure 2. Differentially methylated gene promoters of KRTCAP3 (A), TNNT1 (B ), SEPT8 (C ), CD226 (D), PM20D1 (E ), and FGFR2 (F ) in Han Chinese-
American (yellow), Caucasian-American (pink), and African-American (brown) individuals. Absolute DNA methylation levels at population-specific CpG
sites in gene promoters (low: green; high: red) are displayed for single individuals (n = 269). The distance to the gene transcription start site is indicated.
The samples are ranked according to their average DNA methylation levels (middle panel) at displayed pop-CpGs. Population enrichment (right panel) is
illustrated using absolute sample numbers in a 10-sample window.
Figure 3. Genotype and DNA methylation regulate gene expression of SPATC1L in a conjoined
manner and inversely correlate at the transcription start (TSS) and end site (TES). (A) Schematic overview
of the gene structure of SPATC1L. (B) AF individuals have high levels of promoter DNAmethylation, a TT
phenotype enriched in rs8133082, and reduced expression of SPATC1L. The figure displays the absolute
DNAmethylation levels (low: green; high: red) for four promoter-related pop-CpGs of African-American
(brown), Caucasian-American (pink), and Han Chinese-American (yellow) individuals; the genotype of
rs8133082 for the individual samples (GG, GT, TT); the correlation between DNA methylation
(cg08742575) and the genotype (rs8133082); and the gene expression level (SPATC1L). Samples are
ranked by mean CpG methylation values. (C ) Unlike the promoter, AF individuals have CpG hypo-
methylation, which is positively correlated with SPATC1L gene expression (cg11766577).
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meQTLs, suggesting that the interplay between both layers is
partially independent of the cell-type context. In particular, we
confirmed the presence of blood-related meQTLs in 40.6% of
breast, 38.9% of colon, and 32.6% of lung-tissue samples. It is of
note that meQTLs are located close to the correlated SNP site, with
69% (412 out of 596) presentwithin a 15-kbwindow and 38% (227
out of 596) within 5 kb (Supplemental Fig. S8).
However, for the remaining 32% of pop-CpGs, no direct re-
lationship could be detected between the genetic background and
variability of CpG sites. We excluded the possibility that the ab-
sence of genetic association was a consequence of an uneven
number of SNPs in the 61-Mb region surrounding the pop-CpGs
by showing that both groups harbored similar numbers of SNPs in
the analyzed regions (Supplemental Fig. S9). The analyzed win-
dows also harbored equal coverage of repetitive elements (SINE,
LINE, LTR), and, thus, the same power to identify SNPs (Supple-
mental Fig. S10). Interestingly, gene promoters associated with
potentially epigenetically inherited CpG sites were related to im-
mune response components (FYN, CD226, HIVEP3) (Supplemen-
tal Table S1) and enriched for transcription factor binding sites for
NFKB (z-test; TRANSFAC: FDR = 0.0195; JASPAR: FDR = 0.0057),
a transcription factor involved in the immune defense system,
protecting against, for example, viral (i.e., hepatitis B) and bacterial
(i.e., Shigellosis) pathogen infection. This raises the possibility that
the pathogens in the environment leave stable fingerprints in the
epigenomes of the human host population.
Noteworthy, when we interrogated the three aforementioned
primary tissue types, we found no further genetic associations of
potentially epigenetic inherited CpG sites in 66.0%of cases (93 out
of 141), supporting their genetic independence. In this respect,
proportional analysis detected no differences in the power to de-
tect genotype–epitype associations between the initial LCL sample
set and the primary specimens (Chi-square test; OR: 1.13, P = 0.51),
underlining the reliability of the study design.
Population-specific differential methylation could be useful
in genome-wide association studies of genetic variants
Only 13% (79 out of 596) of SNPs related to differentially meth-
ylated pop-CpGs are located in exonic regions and hence can be
directly associated with functional gene alterations (Supplemental
Table S6). Therefore, we postulated that DNA methylation pres-
ents a little-recognized but highly informative level in the in-
terpretation of genetic variants between human individuals.
Comprehensive analysis of genetic variation in genome-wide as-
sociation studies (GWAS) often reveals genotype–phenotype con-
nections. These include many polymorphisms that are directly
connected with phenotypes, but are located within intergenic or
intronic regions of unknown function. Studying the close in-
terplay between genetic and epigenetic regulation could help in-
terpret these connections, which are otherwise difficult to explain.
In this respect, DNA methylation might display a potent in-
termediate event that could be useful to interpret the GWAS re-
sults. For this reason, we performed model-based gene set analysis
(Bauer et al. 2011) to compare SNPs directly associated with pop-
CpGs and GWA studies available at GWASdb (Li et al. 2012). We
found some interesting associations related to age of menarche,
and HIV control; in particular, we determined highly significant
enrichment for hepatitis B infection through the detection of six
SNPs directly related to CpG sites that were differentially methyl-
ated between populations (Enrichment score: 0.99) (Supplemental
Table S7; Bauer et al. 2011). These six SNPs were located within the
HLA-DPA1 and HLA-DPB1 locus, which is strongly associated with
chronic hepatitis B virus (HBV) infection (Kamatani et al. 2009).
Concordantly, HBV infection risk alleles are more abundant in
populations with a higher incidence of disease, such as those with
Asian or African ancestry. However, none of the SNPs is located in
a coding context, making it difficult to connect genetic variation
and risk phenotype. Functionally, the HLA-DPA1- and HLA-DPB1-
related SNPs were defined as eQTLs and thus directly connected to
gene expression (O’Brien et al. 2011), although the regulatory
mechanism remains elusive.
Here, we integrated GWAS results into differential DNA
methylation analysis, determining a direct correlation between
genetic variation and differences in the methylation of CpGs lo-
cated in the HLA-DPA1 locus. In particular, the 10 HBV infection–
associated SNPs (Kamatani et al. 2009)were significantly correlated
with 17 CpG sites in the HLA-DPA1 locus (Pearson’s correlation,
rho > 0.6) (Fig. 4; Supplemental Table S8). The risk alleles were
associated with altered CpG methylation and occurred at high
frequencies in Asian and African populations. In detail, the risk
alleles were related to DNA hypermethylation in the promoter of
HLA-DPA1, which was inversely correlated with gene expression
(Fig. 4; Supplemental Fig. S11). Hypermethylation of the promoter
of HLA-DPA1 was conjoined with DNA hypomethylation in the
gene body, which is also associated with a lower level of gene ex-
pression (Jones 2012). Hence, we foundDNAmethylation associated
withHLA-DPA1 gene repression in the Asian andAfrican individuals,
identifying the risk alleles for mediating DNA methylation variation
and gene repression. These give rise to variation in cell surface re-
ceptor presentation and altered HBV binding and infection risk.
Consequently, we suggest that DNA methylation could be the un-
identified regulatory event connecting genotype (risk alleles), gene
expression (eQTLs), and phenotype (infection incidence).
Discussion
Epigenetic modification, and DNA methylation in particular,
provides a layer of gene regulation that has a great influence on
phenotypes. It has beenwidely studied in human cancer. However,
outside of the disease context, there are few examples of epigenetic
variations that are directly associated with phenotypic differences.
Interestingly, a recent genome-wide epigenetic analysis of different
casts of honey bees revealedDNAmethylation differences between
nurse and forager bees at different genomic loci, suggesting that
despite being genetically identical, the social behavior of bees is
directly associated with their epigenetic profile (Herb et al. 2012).
Although done in another species, this study gives an insight into
the potential impact of DNA methylation changes on distinct
human phenotypes beyond the disease context. Consistently, we
aimed to determine DNAmethylation differences between human
populations and their association with the natural phenotypic
variation occurring in the human species. Here, using 439 CpG
sites differentially methylated between Caucasian-American, Af-
rican-American, and Han Chinese-American individuals, we were
able to perfectly separate the distinct populations with respect to
their geographical origins and to associate them with distinct
phenotypic characteristics, such as appearance, drug metabolism,
response to external stimuli, sensory perception, and disease sus-
ceptibility. Importantly, local selective pressure was shown to in-
duce the manifestation of epigenetic variants, exemplified by im-
mune and xenobiotic response factors and their potential positive
selection by differences in local pathogen and environmental
pressure.
DNA methylation contributes to human variation
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Taking advantage of the comprehensive characterization of
the analyzed samples at the genetic level, we were able to in-
terrogate genotype–epitype associations to distinguish further
between the two types of inheritance—genotype dependent and
independent. Although, DNAmethylation in general reveals low
dependence on the genotype (Bell et al. 2011, 2012), two-thirds
of population-specific CpG sites were directly associatedwith the
underlying genetic background, suggesting the evolutionarily
set genetic context influences DNA methylation, which sub-
sequently functions as an intermediate regulatory event medi-
ating phenotypic differences between populations. Here, the
hepatitis B infection risk, which is directly related to underlying
genotypes and epitypes, and the consequent enrichment of
these in affected populations is an illustrative example of the
tight interplay between the two layers of organization. Similar
causal connections were concluded by Feinberg and Irizarry from
results obtained from high-resolution DNA methylation pro-
filing of normal human and mouse tissues (Feinberg and Irizarry
2010). These investigators suggested that a change in regional
CpG density over time was responsible for DNA methylation
changes between the species. Genotype–epitype associations in
terms of methylation quantitative trait loci were also observed
in LCL samples from African and European populations (Bell
et al. 2011; Fraser et al. 2012) and human brain samples (Gibbs
et al. 2010; Zhang et al. 2010), highlighting their close con-
nection. Accordingly, variation in the DNA methylation of
population-specific loci followed similar trends to those seen in
genetic variation studies, suggesting that both levels have similar
patterns of variation and underlying related selection criteria
(Li et al. 2008a).
Interestingly, no direct relation to genetic variation could be
detected for one-third of differentially methylated loci, suggesting
Figure 4. Genetic polymorphisms related to HBV infection influence DNA methylation and gene expression at the HLA-DPA1 locus. Using Circos
(Krzywinski et al. 2009), the figure shows a schematic overview of the HLA-DPA1 locus and DNAmethylation, genotype and expression data from African-
American (brown), Caucasian-American (pink), and Han Chinese-American (yellow) individuals: DNA methylation levels (low: green; high: red) of CpG
sites (n = 17) significantly correlated with the genotype of HBV infection-associated SNPs (n = 10) (Kamatani et al. 2009). Samples are ranked bymean CpG
methylation values. SNP-CpG relations are displayed by colored lines. The genotype distribution of SNPs in the HLA-DPA1 locus is shown, which is
significantly correlated with the level of CpG methylation (gray boxes; risk alleles are highlighted in red) (Kamatani et al. 2009). The distribution of
expression levels of HLA-DPA1 is shown in the blue box.
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that the epivariance might be independent of the coding se-
quence (Rando 2012). In this regard, external stimuli such as
toxic xenobiotics (Anway et al. 2005; Zeybel et al. 2012) and
differences in dietary or hormone exposure (de Assis et al. 2012)
or stress (Seong et al. 2011) are known to induce epigenetic
changes with an impact on subsequent generations and may also
have been the source of the differences between populations
observed here. Detecting immune system–related genes enriched
at potentially epigenetically inherited CpG sites suggests that the
impact of pathogens on their host’s DNA profiles (Paschos and
Allday 2010) subsequently leaves footprints in the epigenome
of their progeny. However, we cannot entirely exclude that the
lack of genetic association for these potentially epigenetically
inherited pop-CpG sites is based on unmodeled or unmeasured
components in this study. Although, we applied multivariate
methodology and interrogated large genomic regions, trans-act-
ing polymorphisms or those not present on the SNP array plat-
form might reveal epitype associations not reported as meQTLs.
Herein, using stringent thresholds to identify differentially
methylated CpG sites between the populations, the study design
favored the selection of high-frequency variables and therefore
unmeasured low-frequency polymorphisms were not the scope of
this study, and their absence should have influenced the identifi-
cation of meQTLs onlyminimally. It is of note that environmental
variations between populations (e.g., diet preferences) could have
influenced the epitype of germline cells, but might have also di-
rectly affected the DNAmethylation levels of the somatic cell type
analyzed here.
In conclusion, we have identified DNA methylation differ-
ences that distinguish three major human ethnic groups. Al-
though many of them are associated with underlying genetic
changes, suggesting a direct relationship between the genetic and
epigenetic codes, others stand alone as epigenetic markers and
CpG methylation quantitative trait loci associated with natural
variation in our species. Thus, DNA methylation is a likely
contributor to the different phenotypic characteristics, such as
differences in drug response and disease frequencies that occur
between human populations. From the regulatory point of view,
we suggest a scenario wherein the genetic and epigenetic back-
grounds set the evolutionarily established blueprint, resulting in
phenotypic variation. Detecting distinct pop-CpG sites within
populations suggests that divergence and selection pressure
not only shape the genetic code, but also the DNA methylation
landscape.
Methods
Sample description
DNA samples of 96 unrelated healthy Caucasian-Americans, 96
African-Americans, and 96 Asian-Americans were obtained from
lymphoblastoid cell lines included in the Human Variation panel
(sample sets HD100AA, HD100CAU, HD100CHI; Coriell Cell Re-
positories). These samples had been collected and anonymized by
the National Institute of General Medical Science (NIGMS), and all
subjects had provided written consent for their experimental use.
Sample processing was performed in a randomized manner to
avoid batch effects. Gender distribution (male frequency) and
mean age (6standard deviation) for each ethnicity were 0.5 and
37.36 16.2 yr for Caucasian-American samples, 0.2 and 29.46 9.9
yr for African-Americans, 0.5 and 36.2 6 15.7 yr for the Han Chi-
nese-Americans, respectively. DNA from naive blood samples was
extracted from peripheral blood mononuclear cells of unrelated
healthy Caucasian and Asian donors. These samples had been
collected and anonymized by the Bellvitge Biomedical Research
Institute (IDIBELL) and the National Research Institute for Child
Health andDevelopment (NRICHD), and all subjects had provided
written consent for their experimental use. DNAmethylation data
from naive blood samples of African individuals have been pre-
viously published (Alisch et al. 2012). Gender distribution (male
frequency) andmean age (6standard deviation) for each ethnicity
of naive samples were 0.5 and 27.76 2.8 yr for Caucasian samples,
1.0 and 3.8 6 3.7 yr for Africans, and 0.3 and 33.0 6 3.4 yr for
Asians, respectively.
Genotype and DNA methylation data for primary samples of
normal breast (n = 78), colon (n = 38), and lung (n = 32) tissues were
obtained from The Cancer Genome Atlas (TCGA) data portal
(https://tcga-data.nci.nih.gov/tcga).
Infinium HumanMethylation450 BeadChip
All DNA samples were assessed for integrity, quantity, and purity
by electrophoresis in a 1.3% agarose gel, picogreen quantification,
and nanodrop measurements. All samples were randomly distrib-
uted into 96-well plates. Bisulfite conversion of 500 ng of genomic
DNA was performed using the EZ DNA Methylation Kit (Zymo
Research) following themanufacturer’s instructions. Two hundred
nanograms of bisulfite-converted DNA was used for hybridization
on the HumanMethylation450 BeadChip (Illumina). Briefly, sam-
pleswerewhole-genomeamplified followedby enzymatic end-point
fragmentation, precipitation, and resuspension. The resuspended
samples were hybridized onto the BeadChip for 16 h at 48°C,
then washed. A single nucleotide extension with labeled dideoxy-
nucleotides was performed, and repeated rounds of staining were
applied with a combination of labeled antibodies differentiating
between biotin and DNP.
A three-step normalization procedure was performed using
the lumi (Du et al. 2008) package available for Bioconductor
(Gentleman et al. 2004), within the R statistical environment
(R Development Core Team 2009), consisting of color bias ad-
justment, background level adjustment, and quantile normali-
zation across arrays (Du et al. 2008). The methylation level
(b-value) for each of the 485,577 CpG sites was calculated as the
ratio of methylated signal divided to the sum of methylated and
unmethylated signals plus 100. After the normalization step, we
removed probes related to X and Y chromosomes, and those
with a SNP frequency >1% (The 1000 Genomes Project Con-
sortium 2010) in the probe sequence or interrogated CpG site.
All analyses were performed in human genome version 18 or
19 (hg18/19). However, to exclude regions of potential copy
number variation, we integrated a data set (Redon et al. 2006)
that was available only at the version hg17. Therefore, we
transformed the loci represented on the array platform into the
coordinates of the older genome version ( hg19 to hg17) using
the LiftOver tool fromUCSC. Subsequently, all probes associated
to CNV with a frequency higher than 5% were excluded from
the study.
Hierarchical clustering
Samples were organized by hierarchical clustering using the com-
plete agglomeration method for Manhattan distances. The strength
of the cluster was assessed from 10,000 bootstrap samples using
the pvclust (Suzuki and Shimodaira 2006) package available for
the R statistical environment. We also calculated 10,000 clusters
using 439 random CpG sites to ensure that the cluster was not
generated based on genome-wide differences between the sam-
ples and populations.
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Surrogate variable identification
To identify possible latent factors that influence the methylation
levels, we did a surrogate variable analysis as described in Leek and
Storey (2007). We used the SVA11 R package provided by these
investigators and ran the two-step protocol to identify the number
of latent factors that need to be estimated and to identify the
surrogate variables.
Admixture
To describe the ancestral allele methylation status of each in-
dividual, we discretized the b-values into three stages, simulating
the diploid structure of the human genome. Loci with b-value <
0.33 were annotated as having AA alleles. Those with a b-value >
0.66were designated BB alleles. All other loci were considered to be
AB alleles. We ran the PLINK software (Purcell et al. 2007) with
these data to store the pedigree/phenotype information in PLINK
format, and then used the ADMIXTURE program to perform max-
imum likelihood estimation of individual ancestries from multi-
locus SNPs (with discretized b-values), as described in Alexander
et al. (2009).
Identification of population-specific DNA methylation
(pop-CpGs sites)
To define CpG sites that are differentially methylated between
populations, we excluded outlier samples with an abnormal ge-
nome-wide DNA methylation profile to avoid the influence of
unmodeled sources on the results. By performing PCA of CpG sites
that do not overlap SNPs or CNVs, or that are located in gender-
specific chromosomes (with the first two principal components
explaining 27% of the variance), we excluded 11 Caucasian and
eight African samples that fell outside the 95%confidence interval.
Differential methylation analysis of individual CpG sites for the
three populations was measured by selecting CpG sites with an
absolute difference of the average methylation between two pop-
ulations above 0.12, in terms of b-values (ranging from 0 to 1). An
ANOVA with a Tukey HSD post hoc test was performed, and CpG
sites showing an FDR-adjusted P-value < 0.01were considered to be
differentiallymethylated between populations. Subsequently, a set
of naive blood samples from 10 Caucasians, 10 Africans, and 10
Asians was used as a filter to rule out side effects introduced by EBV
immortalization of the lymphoblastoid cell lines. Therefore, the
arrays were quantile-normalized, and CpG sites with an absolute
difference in the average methylation between populations >0.12
were considered to be population-specific CpG sites (pop-CpGs).
Identification of pop-CpGs sites under local selective pressure
To define pop-CpG sites derived by local selective pressure, we
integrated DNAmethylation data (InfiniumHumanMethylation450
BeadChip) from DNA obtained from whole blood of 14 chimpanzee
individuals (four P. t. schweinfurthii; four P. t. verus; three P. t. troglo-
dytes; and three of unknown origin), using these as the outgroup.
Because the Infinium HumanMethylation450 BeadChip is
designed for use with the human reference genome, we first
mapped the probes to the chimpanzee genome (Pan_troglodytes-
2.1.4), using BWA (Li and Durbin 2009) and allowing a three
edit distance. We retained only the autosomal probes that un-
ambiguously mapped to a single location in the reference chim-
panzee genome and probes with either a perfect match, or one
mismatch in the 59 45 bp and with no mismatches in the 39 5 bp
(closest to the CpG sites that are being assayed). We also excluded
probes with a detection P-value > 0.01 in at least one individual.
This filtering step resulted in the retention of 299,924 probes
(66.6%). Using this conservative subset of CpG sites, we performed
two-color channel signal adjustment and quantile normalization
of human and chimpanzee samples on the pooled signals from
both channels and recalculated the average b-values (Du et al.
2008). CpG sites with a single human outlier population (ANOVA
with Tukey HSD post hoc test, P < 0.05) were considered to have
evolved under local selective pressure.
Expression analysis
Expression data for the analyzed samples were obtained using the
Human Genome U133 Plus 2.0 expression microarray (Affyme-
trix), available in the GEO database (GSE24277). A total of 24
Caucasian-American, six African-American, and one HanChinese-
American samples were excluded because expression data were not
available. Expression arrays were loaded into the R statistical en-
vironment using the affy (Gautier et al. 2004) package, and nor-
malized using the RMA method as described in Irizarry et al.
(2003). Associations between DNA methylation and expression
were calculated using Pearson’s correlation coefficients. P-values
below 0.01 after correction for multiple hypothesis testing were
considered as significant.
meQTL identification
Genotype information for the analyzed samples was obtained
from a set of HumanHap550k and HumanHap650k SNP arrays
(Illumina), available in the GEO database (GSE24260, GSE24274).
Data sets were combined into a single table containing 660,919
unique SNPs. A total of 24 Caucasians, seven African-American,
and two Han Chinese samples were excluded from subsequent
analysis because genotyping data were not available.
meQTLs for the 439 differentially methylated sites were
identified by interrogating SNPs located in a 61-Mb window
flanking the CpG sites. The window was reduced in 100-kb in-
tervals if it contained more than 1000 SNPs. We used the Random
Forest Selection Frequency (RFSF) multivariate method, as de-
scribed in Michaelson et al. (2010), to identify unique SNPs or
additive effects of multiple SNPs on single CpG sites. This method
performs well compared with other methods and enables us to
identify multiple SNPs acting on a feature (Michaelson et al. 2009,
2010).
The Random Forest algorithm is implemented in R in the
randomForest package (Liaw andWiener 2002). First, we called the
Random Forest algorithm to generate 2000 trees for regression and
calculated the selection frequency (SF) of the variables (SNPs)
used in the construction of the regression model. Bias correction
was then applied to the frequencies by subtracting the deviation
between the SF of the variable under the null hypothesis (no as-
sociation between the SNPs and the methylation value) and the
average SF of all variables under the null hypothesis; we used 1000
forests of 10 trees to obtain the SF under the null hypothesis,
generating a methylation matrix from a random distribution, and
applied the correction to the original SF. Eventually, in order to get
a metric of how associated with the epitype the SF of a poly-
morphic site was, we constructed an empirical distribution from
the SFs of 10 forests of 2000 trees by permuting the SNP values
of our samples, reporting a Q-value for every SNP by comparing
its SF with the ones under the null hypothesis.
Enrichment analysis of GWAS-associated polymorphisms
To establish a causal relationship between genetic variability,
DNA methylation level, and distinct phenotypes, we determined
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enrichment of meQTL-related SNPs in the entire set of GWA
studies available at GWASdb (Li et al. 2012) using model-based
gene set analysis (Bauer et al. 2011). The method analyzes all cat-
egories at once by embedding them in a Bayesian network. Prob-
abilistic inference is used to identify the active categories, giving
a score that is simply the probability that associates a natural
weight to each term, reflecting a measure of certainty of its in-
volvement in the process.
Sequence motif enrichment analysis
De novo motif discovery of promoter-related, intragenic, or
intergenic pop-CpGs was performed using GADEM software
(Li 2009), using a window of maximal 50 bp flanking the CpG
of interest (E-value < 0.05). Subsequently, sequence motifs were
assigned to human transcription factor binding sites using JASPAR
(Bryne et al. 2008), while removing artifactual and background
motifs using MotIV (Motif Identification and Validation) (Mercier
et al. 2011). We calculated the enrichment P-values based on the
hypergeometric distribution of motif matches at pop-CpG sites,
relative to their abundance in the search space (DNA methylation
BeadChip). The hypergeometric test reports the probability to
obtain the number ofmotif hits in the pop-CpG set comparedwith
the number present in all CpG sites represented on the BeadChip.
The P-values were calculated separately for promoter-, gene body-
related, and intergenic CpG sites.
Transcription factor enrichment analysis for pop-CpG sites
without genetic association located in promoters was performed
using PSCAN (Zambelli et al. 2009). Transcription factor bind-
ing annotations defined by TRANSFAC or JASPAR were used in-
dependently. The gene promoter region was defined as 950 and
+50 bp to the gene transcription start site. Z-test P-values were
corrected for multiple hypotheses testing using the Bonferroni
method.
Data access
The DNA methylation data generated for this study have been
submitted to the NCBI Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo/) under accession number GSE36369.
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